Edition:
United Kingdom

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

3.10USD
21 Sep 2018
Change (% chg)

$0.05 (+1.64%)
Prev Close
$3.05
Open
$3.10
Day's High
$3.10
Day's Low
$2.95
Volume
590,182
Avg. Vol
124,727
52-wk High
$5.80
52-wk Low
$2.20

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $165.38
Shares Outstanding(Mil.): 31.35
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.89 -- --
ROI: -68.80 15.07 14.61
ROE: -79.58 16.59 16.33

BRIEF-Adamis Pharmaceuticals Says Working With Sandoz To Prepare Symjepi Launch

* ADAMIS PHARMACEUTICALS - WORKING CLOSELY WITH SANDOZ TO PREPARE A SUCCESSFUL LAUNCH FOR SYMJEPI

27 Aug 2018

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,529.00 -2.40

Earnings vs. Estimates